Core Viewpoint - The major shareholders of Guai Bao Pet are planning to reduce their holdings by up to 7.61 million shares, representing 1.90% of the total share capital, during the period from March 6 to June 5, 2026, following a significant decline in the company's stock price and a drop in net profit [1][3]. Stock Price and Financial Performance - The company's stock price has been on a downward trend, falling from a peak of 125.38 CNY per share in mid-2025 to 60.82 CNY as of February 13, 2026, marking a decline of 51.5% [2]. - The reduction in stock price has led to a significant decrease in the cash amount that can be realized from the planned share reduction [2]. Company Fundamentals - In the third quarter of 2025, the company experienced its first quarterly net profit decline since its listing, with a year-on-year decrease of 16.65% in net profit attributable to shareholders [3]. - The decline in profit is attributed to increased sales expenses, reduced foreign exchange gains, and rising depreciation costs, which have contributed to a slowdown in performance and negatively impacted market sentiment [3]. Capital and Technical Analysis - From February 9 to 13, 2026, there was a continuous net outflow of main funds, with a total net selling amount of 18.6372 million CNY, indicating a cautious attitude among institutional investors [4]. - Technically, the stock price has fallen below all major moving average supports, with the lower Bollinger Band positioned at 59.76 CNY, suggesting a weak short-term trend [4].

Core Viewpoint - The company, Guibao Pet (301498.SZ), is expanding its production capabilities internationally, with a focus on long-term strategies and brand development, unaffected by short-term profit fluctuations [2]. Group 1: Company Expansion - Guibao Pet currently has a production base in Thailand and is in the process of building a high-end pet food project in New Zealand [2]. - The company emphasizes a long-term commitment to its self-owned brand strategy, prioritizing brand share over immediate profits [2]. Group 2: Strategic Focus - The company is dedicated to the core business of pet food, pursuing a strategy of high-end, functional, and global development [2]. - Guibao Pet aims to build long-term barriers through product upgrades, channel expansion, cost optimization, and research transformation [2]. Group 3: Market Positioning - The pet industry has significant market potential, with various companies adopting unique development paths [2]. - Guibao Pet is committed to differentiated competition, continuously strengthening its advantages in the market [2].

Core Viewpoint - The company, Guibao Pet (301498), has not disclosed specific new product launch plans or channel cooperation details, emphasizing that relevant operational data and performance contributions should be referenced from the company's periodic reports [1] Group 1 - The company responded to investor inquiries on its interactive platform regarding its business secrets [1] - The company maintains that it has not publicly shared specific plans related to new product launches or partnerships [1] - Investors are advised to refer to the company's regular reports for accurate operational data and performance contributions [1]

Group 1 - The company, Guibao Pet (301498), stated that it strictly adheres to regulatory requirements for information disclosure and has not disclosed or committed to specific growth rates or gross margin targets for 2026 [1] - The company emphasized that relevant operational data should be referenced from its periodic reports [1]

Core Viewpoint - The company, Guibao Pet, confirmed its commitment to timely and compliant reporting of its 2025 annual report and the first quarter report of 2026 [2] Group 1 - The company will continue to launch and promote new products in 2026 [2] - The company's goals will be supported by product strength and research and development capabilities [2]

Group 1 - The company, Guibao Pet, is committed to cash dividends as a way to reward investors and is exploring other feasible methods for shareholder returns [2] - The company aims to continuously improve and establish a diversified shareholder return mechanism to better appreciate the support and companionship of its shareholders [2]

Group 1 - The core viewpoint of the article is that the company, Guibao Pet, is committed to maintaining stable profitability in its overseas business by aligning its strategies with market conditions [2] - The company is actively addressing risks associated with fluctuations in overseas markets through initiatives such as a global supply chain layout [2] - Investors are advised to refer to the company's regular reports for relevant operational data [2]

Core Viewpoint - The A-share market concluded the Year of the Snake with all major indices showing positive performance, with the Shanghai Composite Index rising by 25.58%, the Shenzhen Component Index increasing by 38.84%, and the ChiNext Index leading with a remarkable gain of 58.73% [1]. Summary by Category Market Performance - The Year of the Snake saw significant gains across major indices, with the Shanghai Composite Index up by 25.58%, the Shenzhen Component Index up by 38.84%, and the ChiNext Index up by 58.73% [1]. Stock Performance - Despite the overall positive index performance, certain stocks experienced substantial declines. The top ten stocks with the largest declines, excluding newly listed stocks and ST stocks, are: 1. Kang Le Wei Shi 2. Hua Lian Shares 3. Tian Jian Shares 4. Wan Tai Biological 5. Chuan Yin Holdings 6. Guai Bao Pet 7. Yi Hua Lu 8. Ai Bo Medical 9. Long Da Mei Shi 10. Bei Shi Da Ke [1].

Group 1 - The core transaction of Guibao Pet Company on February 13 involved a block trade of 146,900 shares, with a total transaction value of 8.9345 million yuan, accounting for 6.68% of the total trading volume for that day [1][2] - The transaction price was 60.82 yuan per share, which remained stable compared to the market closing price of 60.82 yuan [1][2]

Investment Rating - The report maintains an investment rating of "Outperform" for the agriculture, forestry, animal husbandry, and fishery industry [8] Core Insights - The report highlights the stabilization and rebound of pig prices, with the January average price for external three yuan pigs at 12.68 yuan/kg, reflecting a month-on-month increase of 9.58% but a year-on-year decrease of 19.52% [8][21] - The "No. 1 Document" emphasizes the promotion of biological breeding industrialization, which is crucial for achieving self-sufficiency in seed sources and enhancing grain production capacity [19][20] - The pet food sector shows a positive trend, with December 2025 pet food exports reaching 37,700 tons, a year-on-year increase of 15.49% [35] Summary by Sections Market Review - In January 2026, the agriculture, forestry, animal husbandry, and fishery index rose by 1.63%, ranking 23rd among 30 sectors, while the Shanghai and Shenzhen 300 index increased by 1.65% [11] - The animal health sector performed well, while the forestry processing sector saw declines [11] Biological Breeding - The "No. 1 Document" calls for the implementation of actions to revitalize the seed industry and accelerate the breeding and promotion of breakthrough varieties [19][20] - The focus is on stabilizing grain and oil production and enhancing yield levels [19] Livestock and Poultry Data Tracking - Pig prices showed a rebound in January, with a tight supply supporting price increases [21] - The average price of white feather chickens rose to 3.73 yuan/jin, with a month-on-month increase of 1.36% [28] Pet Food Exports - Pet food exports maintained a year-on-year growth, with total exports for 2025 reaching 361,300 tons, a 7.78% increase [35] Investment Recommendations - The report suggests focusing on companies such as Muyuan Foods, Pulaike, Qiule Seed Industry, Guobao Pet, Zhongchong Co., and Petty Holdings, as the industry’s price-to-earnings and price-to-book ratios are below historical averages, indicating potential for valuation recovery [8]